Should You Sell Ocean Biomedical Inc (OCEA) And Go Away This Year?

Ocean Biomedical Inc (NASDAQ:OCEA) currently has a daily average trading volume of 33.85M but it saw 5201370 shares traded in last market. With a market cap of 11.03M USD, the company’s current market price of $0.08 came falling about -7.43 while comparing to the previous closing price of $0.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.97 and as low as $0.08. In the recent trading on the day, stock has struck highest price mark of $0.0777 while lowest mark touched by it was $0.0833.

Taking a look at 20-day trading activity of Ocean Biomedical Inc (OCEA) gives us an average price of $0.1104, while its current price level is -98.42% below from 52-week high level whereas it is 4.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3045 while that of 200 days or SMA-200 reads an average of $0.8426. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.75% during that period while stretching the period over a month that increases to 17.36%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.34 which implies that the stock is in oversold territory.

Over the week, OCEA’s stock price is moving -14.67% down while it is -46.96% when we observe its performance for the past one month. Year-to-date it is -85.80% down and over the past year, the stock is showing a downside performance of -98.59%.

The company is expected to be releasing its next quarterly report on 2024-Apr-14, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Ocean Biomedical Inc’s total number of outstanding shares is 140.59M with 17.04% of that held by the insiders while 2.60% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1691.47%. Stock’s beta reads 1.41. Its return on asset (ROA) is -2461.30% on average.